Search
for
Sort by
Research 871–900 of 1000+
- Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Skin inflammation activates intestinal stromal fibroblasts and promotes colitis
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Impaired Hair Follicle Morphogenesis and Cycling with Abnormal Epidermal Differentiation in nackt Mice, a Cathepsin L-Deficient Mutation
- Management of psychiatric disorders with HIV and dermatological disorders
- Cisd2 deficiency impairs neutrophil function by regulating calcium homeostasis via Calnexin and SERCA
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Evaluation of vitamin D in pediatric alopecia areata: A case–control study of thirty patients in a tertiary care hospital
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Immune therapies for alopecia areata: evidence and new perspectives
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- A Spontaneous Deletion within the Desmoglein 3 Extracellular Domain of Mice Results in Hypomorphic Protein Expression, Immunodeficiency, and a Wasting Disease Phenotype
- Vaccines, adjuvants and autoimmunity
- Skin Microbiome, Metabolome and Skin Phenome, from the Perspectives of Skin as an Ecosystem
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- New Modalities in the Treatment of Refractory Alopecia Areata
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Murine Cytomegalovirus is Not Associated With Alopecia Areata in C3H/HeJ Mice
- Skin manifestations associated with systemic diseases – Part I
- Defective trophoblast function in mice with a targeted mutation of Ets2
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Probiotics in Dermatology: An Evidence-based Approach
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review